Cohance Lifesciences Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
549.90 +6.35 (1.17%)Updated : 04 Dec 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net 13.75-6.35-26.74-48.45
Net Changein Cash 38.17-17.5720.2437.38
Cash Taxes Paid 83.44109.95145.76184.26
Net Income/ Starting Line 343.92405.67559.73667.59
Changesin Working Capital -115.58-62.54-139.99-378.22
Cashfrom Operating Activities 288.16358.48457.20330.00
Cash Interest Paid 10.437.4511.566.23
Cashfrom Financing Activities 3.32-13.80-241.95-156.41
Depreciation/ Depletion 77.4951.8146.4638.26
Other Investing Cash Flow Items Total -99.59-310.4790.91-61.02
Capital Expenditures -155.71-51.79-285.91-75.19
period Type ----
Foreign Exchange Effects 1.990.000.000.00
Non- Cash Items -17.67-36.46-9.002.38
Financing Cash Flow Items -10.43-7.45-11.56-6.14
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -255.30-362.25-195.01-136.21
Total Cash Dividends Paid ---203.65-101.83
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,561.20+19.40(1.26%)
1,594.35+16.05(1.02%)
1,525.00-14.00 (-0.91%)
295.90-1.95 (-0.65%)